Our Latest News
Our Science
May 30, 2024
Redefining R&D: How Immunoscience is Driving the Pipeline of the Future
United by Purpose
Each of us plays a unique role in bringing our purpose to life.
Sanofi X Paris 2024
We’re proud to be premium partner of Paris 2024.
Science and sport aren’t that different. Just like athletes do, we overcome setbacks to keep moving forward, not just for ourselves, but for our patients, colleagues, families and friends.
About Us
Who We Are
We are an innovative global healthcare company.
Our Pipeline
5
Therapeutic areas
77
Compounds in clinical development
28
Clinical trials in phase 3
Explore Career Opportunities
You'll be surprised what you can achieve at Sanofi. Discover your future here.
Our Latest Press Releases
May 31, 2024
Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan
May 31, 2024
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
May 31, 2024
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with type 2 inflammation